LANXESS AG (LXS.DE) Fundamental Analysis & Valuation

FRA:LXS • DE0005470405

16.83 EUR
-1.2 (-6.66%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This LXS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall LXS gets a fundamental rating of 3 out of 10. We evaluated LXS against 66 industry peers in the Chemicals industry. While LXS seems to be doing ok healthwise, there are quite some concerns on its profitability. LXS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. LXS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year LXS was profitable.
  • LXS had a positive operating cash flow in the past year.
  • LXS had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years LXS had a positive operating cash flow.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • LXS's Return On Assets of -2.97% is on the low side compared to the rest of the industry. LXS is outperformed by 71.21% of its industry peers.
  • The Return On Equity of LXS (-6.23%) is worse than 71.21% of its industry peers.
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • In the last couple of years the Operating Margin of LXS has declined.
  • LXS has a worse Gross Margin (20.52%) than 69.70% of its industry peers.
  • LXS's Gross Margin has declined in the last couple of years.
  • LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.52%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. LXS.DE Health Analysis

2.1 Basic Checks

  • LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LXS remains at a similar level compared to 1 year ago.
  • LXS has more shares outstanding than it did 5 years ago.
  • LXS has a better debt/assets ratio than last year.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • LXS has an Altman-Z score of 1.89. This is not the best score and indicates that LXS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LXS's Altman-Z score of 1.89 is on the low side compared to the rest of the industry. LXS is outperformed by 65.15% of its industry peers.
  • The Debt to FCF ratio of LXS is 22.13, which is on the high side as it means it would take LXS, 22.13 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 22.13, LXS is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • A Debt/Equity ratio of 0.62 indicates that LXS is somewhat dependend on debt financing.
  • LXS has a worse Debt to Equity ratio (0.62) than 62.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Altman-Z 1.89
ROIC/WACCN/A
WACC4.49%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • LXS has a Current Ratio of 2.60. This indicates that LXS is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of LXS (2.60) is better than 80.30% of its industry peers.
  • A Quick Ratio of 1.29 indicates that LXS should not have too much problems paying its short term obligations.
  • LXS has a better Quick ratio (1.29) than 68.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.29
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. LXS.DE Growth Analysis

3.1 Past

  • LXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.28%.
  • Measured over the past years, LXS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.38% on average per year.
  • The Revenue has decreased by -6.82% in the past year.
  • The Revenue has been decreasing by -1.32% on average over the past years.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%

3.2 Future

  • LXS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.11% yearly.
  • LXS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.69% yearly.
EPS Next Y-79.53%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
EPS Next 5Y-1.11%
Revenue Next Year-10.25%
Revenue Next 2Y-5.69%
Revenue Next 3Y-2.95%
Revenue Next 5Y-0.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. LXS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • LXS is valuated rather expensively with a Price/Earnings ratio of 17.53.
  • Based on the Price/Earnings ratio, LXS is valued a bit cheaper than the industry average as 69.70% of the companies are valued more expensively.
  • LXS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.83.
  • With a Price/Forward Earnings ratio of 26.88, LXS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of LXS indicates a slightly more expensive valuation: LXS is more expensive than 63.64% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, LXS is valued at the same level.
Industry RankSector Rank
PE 17.53
Fwd PE 26.88
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LXS indicates a rather cheap valuation: LXS is cheaper than 83.33% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, LXS is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.98
EV/EBITDA 6.09
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • LXS's earnings are expected to decrease with -8.29% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LXS.DE Dividend Analysis

5.1 Amount

  • LXS has a yearly dividend return of 0.52%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.21, LXS is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.82, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The Dividend Rate of LXS has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-4.12%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

More info and screens

Find the best dividend stocksShow peers with best dividend

LXS.DE Fundamentals: All Metrics, Ratios and Statistics

LANXESS AG

FRA:LXS (3/3/2026, 7:00:00 PM)

16.83

-1.2 (-6.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners73.38%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.45B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts55
Price Target19.72 (17.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)3.09%
PT rev (3m)-9.93%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-2.37%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.19%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-2.23%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 17.53
Fwd PE 26.88
P/S 0.25
P/FCF 12.98
P/OCF 3.36
P/B 0.37
P/tB 0.86
EV/EBITDA 6.09
EPS(TTM)0.96
EY5.7%
EPS(NY)0.63
Fwd EY3.72%
FCF(TTM)1.3
FCFY7.71%
OCF(TTM)5
OCFY29.73%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.52%
FCFM 1.9%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Debt/EBITDA 4.55
Cap/Depr 50.71%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion 81.82%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.29
Altman-Z 1.89
F-Score6
WACC4.49%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-79.53%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
EPS Next 5Y-1.11%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-10.25%
Revenue Next 2Y-5.69%
Revenue Next 3Y-2.95%
Revenue Next 5Y-0.69%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1008.93%
EBIT Next 3Y134.6%
EBIT Next 5Y73.07%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%

LANXESS AG / LXS.DE FAQ

Can you provide the ChartMill fundamental rating for LANXESS AG?

ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.


Can you provide the valuation status for LANXESS AG?

ChartMill assigns a valuation rating of 4 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.


What is the profitability of LXS stock?

LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.


Can you provide the financial health for LXS stock?

The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.


What is the expected EPS growth for LANXESS AG (LXS.DE) stock?

The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -79.53% in the next year.